Moderna promotes ‘superior’ omicron-fighting booster

Compared to the company's original two-shot vaccine results, Moderna found a "superior neutralizing antibody response" in its booster bivalent candidate targeting the COVID-19 omicron strain. 

Read the full post at Becker's Hospital Review - Healthcare News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive